Results for tag: "Acute Respiratory Distress Syndrome"

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition that affects the lungs and is a major cause of mortality in critically ill patients. It is characterized by severe inflammation of the lungs, leading to fluid accumulation in the alveoli and impaired gas exchange. ARDS is most commonly caused by sepsis, pneumonia, and trauma, and is a major focus of pulmonary medicine. Treatment of ARDS involves supportive care, such as mechanical ventilation, oxygen therapy, and medications to reduce inflammation. In recent years, there has been an increased focus on the development of novel therapies for ARDS, such as extracorporeal membrane oxygenation (ECMO) and surfactant therapy. These therapies have the potential to improve outcomes for patients with ARDS. Companies in the ARDS market include Medtronic, Edwards Lifesciences, Getinge, and Maquet. Show Less Read more